Company Analysis

Tandem Diabetes Care, Inc. (TNDM)

Nasdaq: TNDM · Surgical & Medical Instruments & Apparatus · San Diego, CA · filing with the SEC since 2008
Grade5.0
◀ Past 5.8● Present 5.3▶ Future 3.7
1 est.

Filings

333 filings since 2017 beside 670 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 36 days after the quarter ended. The proxy statement was last filed Apr 7, 2026.

Filings a yearinsider forms included
93105115121121959778
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest May 21, 2026.SEC letters: 7 in the last 36 months, the newest Jun 26, 2025.
Insider forms 670

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 13, 2026 8-K item 8.01 Other event · Current reportThe SI's read Tandem Diabetes Care received FDA 510(k) clearance on November 12, 2026 for a tubeless version of its Tandem Mobi insulin pump, with an infusion set cleared for up to 7 days of wear. The company said full commercial launch in the United States is planned for the first half of 2027. The tag is beneficial because the clearance adds a new product option to its pump line. Nov 12, 2026
Nov 9, 2026 SCHEDULE 13G Large holder notice
Nov 5, 2026 10-Q Quarterly report Sep 30, 2026
Nov 5, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
May 28, 2026 SD Conflict minerals report
May 27, 2026 S-8 Employee stock plan registration
May 21, 2026 8-K items 3.03, 5.02, 5.07, 9.01 Change to shareholders' rights; Officer or director change; Shareholder vote · Current report May 20, 2026
May 15, 2026 8-K item 5.02 Officer or director change · Current report May 11, 2026
May 7, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 2.02, 9.01 Results released · Current report
May 5, 2026 SCHEDULE 13G Large holder notice
Apr 30, 2026 SCHEDULE 13G Large holder notice
Apr 29, 2026 SCHEDULE 13G Large holder notice
Apr 8, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 7, 2026 DEFA14A Extra proxy material
Apr 7, 2026 DEF 14A Proxy statement Dec 31, 2025
Mar 27, 2026 PRE 14A Preliminary proxy statement Dec 31, 2025
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 27, 2026 8-K items 1.01, 2.03, 3.02, 8.01, 9.01 Major agreement signed; New debt or obligation taken on; Shares sold without registration; Other event · Current report Feb 23, 2026
Feb 19, 2026 10-K Annual report Dec 31, 2025
Feb 19, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Dec 30, 2025 8-K items 5.03, 9.01 Charter, bylaw or fiscal-year change · Current report Dec 26, 2025
Nov 13, 2025 SCHEDULE 13G Large holder notice
Nov 12, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Nov 7, 2025
Nov 6, 2025 10-Q Quarterly report Sep 30, 2025
Nov 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 7, 2025 8-K item 8.01 Other event · Current report Aug 6, 2025
Aug 6, 2025 10-Q Quarterly report Jun 30, 2025
Aug 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 26, 2025 UPLOAD SEC comment letter
Jun 25, 2025 CORRESP Reply to the SEC
Jun 11, 2025 UPLOAD SEC comment letter
May 29, 2025 SD Conflict minerals report
May 23, 2025 8-K items 1.01, 5.07 Major agreement signed; Shareholder vote · Current report May 21, 2025
May 23, 2025 CORRESP Reply to the SEC
May 20, 2025 8-K item 8.01 Other event · Current report May 16, 2025
40 of 333 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton TNDM · research, not advice